BIOMAT Database Logo BIOMAT Database Logo

Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. 1998

J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Division of Reproductive Endocrinology and Infertility, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-1247, USA.

OBJECTIVE To evaluate the usefulness of serum estradiol levels obtained on the fourth day of gonadotropin stimulation in predicting the likelihood of pregnancy during controlled ovarian hyperstimulation (COH) using luteal phase leuprolide acetate (LA). METHODS A 4-year retrospective analysis of day 4 estradiol levels and subsequent clinical pregnancy and delivery rates. METHODS A university hospital tertiary referral center. METHODS Couples undergoing IVF treatment. METHODS Primary outcome measures included clinical pregnancy and delivery rates. Secondary outcome measures included the number of oocytes retrieved and the number of embryos available for transfer per COH cycle. RESULTS The clinical pregnancy and delivery rates for cycles with day 4 estradiol levels of >75 pg/mL were 42.3% (30/71) and 32.4% (23/71), respectively. These rates differed significantly from those for cycles with day 4 estradiol levels of < or = 75 pg/mL, which were only 9.1% (4/44) and 6.8% (3/44), respectively. The number of oocytes retrieved and the number of embryos available for transfer for cycles with day 4 estradiol levels of >75 pg/mL also differed significantly from those for cycles with day 4 estradiol levels of < or = 75 pg/mL (11.4 and 7.8 versus 6.8 and 4.3, respectively). CONCLUSIONS Estradiol levels obtained on the fourth day of gonadotropin therapy are highly predictive of successful ovulation induction and pregnancy outcome in cycles using luteal phase LA.

UI MeSH Term Description Entries
D008297 Male Males
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections

Related Publications

J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.
February 2005, Journal of assisted reproduction and genetics,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle.
February 2004, Human reproduction (Oxford, England),
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Controlled ovarian hyperstimulation and IVF pregnancy prognosis.
January 2013, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF.
October 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
October 2008, Fertility and sterility,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI.
June 2017, Facts, views & vision in ObGyn,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol.
September 1997, Fertility and sterility,
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
March 2007, Human reproduction (Oxford, England),
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy.
November 2014, Human reproduction (Oxford, England),
J Y Phelps, and A S Levine, and T N Hickman, and H A Zacur, and E E Wallach, and E L Hinton
Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET.
June 2016, Scientific reports,
Copied contents to your clipboard!